Novo Nordisk Shares Drop 5% Following Trump's Pledge to Cut Weight-Loss Drug Prices
Shares of Novo Nordisk slid about 5% in early trading Friday after former U.S. President Donald Trump said Thursday that prices for the Danish pharmaceutical company’s top-selling weight-loss medication would be reduced.
More News 
